TY - JOUR
T1 - Gender differences in utilization of services and tobacco cessation outcomes at a state quitline
AU - Allen, Alicia M.
AU - Yuan, Nicole P.
AU - Wertheim, Betsy C.
AU - Krupski, Laurie
AU - Bell, Melanie L.
AU - Nair, Uma
N1 - Publisher Copyright:
© 2018 Society of Behavioral Medicine 2018. All rights reserved.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Research suggests that women may have poorer tobacco cessation outcomes than men; however, the literature is somewhat mixed. Less is known about gender differences in cessation within quitline settings. This study examined gender differences in the utilization of services (i.e., coaching sessions, pharmacotherapy) and tobacco cessation among callers to the Arizona Smokers' Helpline (ASHLine). The study sample included callers enrolled in ASHLine between January 2011 and June 2016. We tracked number of completed coaching sessions. At the 7-month follow-up, callers retrospectively reported use of cessation pharmacotherapy (gum, patch, or lozenge), as well as current tobacco use. Associations between gender and tobacco cessation were tested using logistic regression models. At month 7, 36.4% of women (3,277/9,004) and 40.3% of men (2,960/7,341) self-reported 30-day point prevalence abstinence. Compared to men, fewer women reported using pharmacotherapy (women: 71.4% vs. men: 73.6%, p =. 01) and completed at least five coaching sessions (women: 35.1% vs. men: 38.5%, p <. 01). After adjusting for baseline characteristics, women had significantly lower odds of reporting tobacco cessation than men (OR = 0.91, 95% CI: 0.84 to 0.99). However, after further adjustment for use of pharmacotherapy and coaching, there was no longer a significant relationship between gender and tobacco cessation (OR: 0.96, 95% CI: 0.87 to 1.06). Fewer women than men reported tobacco cessation. Women also had lower utilization of quitline cessation services. Although the magnitude of these differences were small, future research on improving the utilization of quitline services among women may be worth pursuing given the large-scale effects of tobacco.
AB - Research suggests that women may have poorer tobacco cessation outcomes than men; however, the literature is somewhat mixed. Less is known about gender differences in cessation within quitline settings. This study examined gender differences in the utilization of services (i.e., coaching sessions, pharmacotherapy) and tobacco cessation among callers to the Arizona Smokers' Helpline (ASHLine). The study sample included callers enrolled in ASHLine between January 2011 and June 2016. We tracked number of completed coaching sessions. At the 7-month follow-up, callers retrospectively reported use of cessation pharmacotherapy (gum, patch, or lozenge), as well as current tobacco use. Associations between gender and tobacco cessation were tested using logistic regression models. At month 7, 36.4% of women (3,277/9,004) and 40.3% of men (2,960/7,341) self-reported 30-day point prevalence abstinence. Compared to men, fewer women reported using pharmacotherapy (women: 71.4% vs. men: 73.6%, p =. 01) and completed at least five coaching sessions (women: 35.1% vs. men: 38.5%, p <. 01). After adjusting for baseline characteristics, women had significantly lower odds of reporting tobacco cessation than men (OR = 0.91, 95% CI: 0.84 to 0.99). However, after further adjustment for use of pharmacotherapy and coaching, there was no longer a significant relationship between gender and tobacco cessation (OR: 0.96, 95% CI: 0.87 to 1.06). Fewer women than men reported tobacco cessation. Women also had lower utilization of quitline cessation services. Although the magnitude of these differences were small, future research on improving the utilization of quitline services among women may be worth pursuing given the large-scale effects of tobacco.
KW - Cessation
KW - Gender differences
KW - Smoking
KW - Tobacco
UR - http://www.scopus.com/inward/record.url?scp=85078512765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078512765&partnerID=8YFLogxK
U2 - 10.1093/tbm/iby083
DO - 10.1093/tbm/iby083
M3 - Article
C2 - 30099557
AN - SCOPUS:85078512765
SN - 1869-6716
VL - 9
SP - 663
EP - 668
JO - Translational behavioral medicine
JF - Translational behavioral medicine
IS - 4
ER -